In an effort to improve health care quality by fostering collaboration, a consortium of Medication Safety Officers from ASMSO have agreed to work together to enhance the knowledge of, and leading to a reduction in medication administration errors and readmission rates in acute care hospitals.
Why have those particular patient populations been singled out as worthy of attention? The literature suggests that, in each case, they continue to be high risk; errors are more frequent and the potential for catastrophic consequence is higher in these patient populations relative to the general adult population:
Taken together, these observations from the literature and recent guideline updates suggest that gaps in practice exist in these patient populations – gaps that the proposed learning activities will attempt to bridge.
In this online free CME / CE program , the presentations will be conducted using a case study format identifying areas of safety that have been successful based upon each of the practice areas noted. These presentations will achieve objectives including; Identify factors of the patient population that increase the risk for medication errors, discuss risk reduction strategies for the particular patient population that can be applied to the medication-use process, completing, development of a list of root causes of medication administration errors, determining the economic cost to the system of these errors, development of data collection protocols, and an effort in the participating hospitals to utilize this information to reduce medication administration errors at their facilities.
Agenda
Healthcare professionals, including oncologists, and other physicians, pharmacists, and mid-level practitioners working in acute care hospitals and other healthcare settings.
Commercial Support Disclosure: This program is supported by educational grants from Boehringer Ingelheim and Hospira.
Release Date: March 04, 2013 -- Expiration Date: March 04, 2015
Faculty: Karen Smethers, PharmD, BCOP
By the end of the session the participant will be able to:
ACCREDITATION FOR THIS COURSE HAS EXPIRED. YOU MAY VIEW THE PROGRAM, BUT CME / CE IS NO LONGER AVAILABLE AND NO CERTIFICATE WILL BE ISSUED.
As an provider of continuing medical education, it is the policy of ScientiaCME to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, faculty and educational planners must disclose any significant relationships with commercial interests whose products or devices may be mentioned in faculty presentations, and any relationships with the commercial supporter of the activity. The intent of this disclosure is to provide the intended audience with information on which they can make their own judgments. Additionally, in the event a conflict of interest (COI) does exist, it is our policy to ensure that the COI is resolved in order to ensure the integrity of the CME activity. For this CME activity, any COI has been resolved thru content review by ScientiaCME.
Faculty Disclosure: Karen Smethers, BS, PharmD, BCOP reports that he has no relevant financial disclosures.
Disclosures of Educational Planner: Charles Turck, PharmD is an officer and part owner of ScientiaCME, LLC. ScientiaCME has received grants from the commercial supporters of this program.
Disclosures of Educational Planner: Ambra King, PharmD (ASMSO) has no financial disclosures.
Commercial Support Disclosure: This program is supported by educational grants from Boehringer Ingelheim and Hospira.
*Required to view Printable PDF Version
Please take a few minutes to participate in the optional pre-test. It will help us measure the knowledge gained by participating in this activity.